Brief: Almirall Divests Algidol And Out-Licenses Sekisan In Spain
Jan 31 (Reuters) - Almirall SA ALM.MC :
* DIVESTS ALGIDOL AND OUT-LICENSES SEKISAN IN SPAIN
* TRANSACTION FOR AN UPFRONT AMOUNT OF €12 MILLION PLUS
UNCONDITIONAL FUTURE PAYMENTS
Source text in Workspace: urn:newsml:reuters.com:*:nCNMbNm2l9
Further company coverage: ALM.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Almirall
See all newsBrief: Almirall Says Phase 3B Adlong Clinical Study Show Treatment Outcomes With Up To Five Years Of Lebrikizumab
Brief: Almirall And CrystalO To Discover, Develop Novel Small Molecules In Medical Dermatology
Almirall shares rise as lower costs beat EBITDA estimates
Brief: Almirall, Certest Biotec Sign Deal to Develop Rare Dermatology Treatments
Spanish stocks - Factors to watch on July 24